Xanthones, thioxanthones and acridinones as DNA-PK inhibitors
US8404681B2 · kind B2 · utility
6Cited by
15References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 19, 2004 |
| Grant date | Mar 26, 2013 |
| Priority date | — |
| Expiry date | Jan 30, 2028 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07F9/6561
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compound that inhibit DNA-dependent protein kinase, compositions comprising the compounds, methods of inhibiting the DNA-PK biological activity, methods of sensitizing cells the agents that cause DNA lesions, and methods of potentiating cancer treatment are disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.